During the past decade, Tennessee Oncology PLLC- Centennial Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tennessee Oncology PLLC- Centennial Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Novartis Pharmaceuticals" with 3 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Akeso" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology PLLC- Centennial Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Akesobio Australia Pty Ltd" with 1 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Oncology PLLC- Centennial Medical Center" are "Colorectal Cancer" (2 trials), "Endometrial Clear Cell Adenocarcinoma" (2 trials), "Endometrial Serous Adenocarcinoma" (2 trials), "Stage II Uterine Corpus Cancer AJCC v7" (2 trials) and "Adenocarcinoma of the Colon" (1 trials). Many other conditions were trialed in "Tennessee Oncology PLLC- Centennial Medical Center" in a lesser frequency.

Most popular intervention types in "Tennessee Oncology PLLC- Centennial Medical Center" are "Drug" (17 trials), "Other" (6 trials), "Biological" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Paclitaxel" (3 trials), "oxaliplatin" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Oncology PLLC- Centennial Medical Center" are 13 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tennessee Oncology PLLC- Centennial Medical Center". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Tennessee Oncology PLLC- Centennial Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Oncology PLLC- Centennial Medical Center, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".